sulfur hexafluoride has been researched along with Brain Ischemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assmus, J; Kurz, KD; Kvistad, CE; Logallo, N; Nacu, A; Naess, H; Neckelmann, G; Thomassen, L; Waje-Andreassen, U; Øygarden, H | 1 |
| Ballotta, E; Baracchini, C; Causin, F; Farina, F; Favaretto, S; Kulyk, C; Palmieri, A; Viaro, F | 1 |
| Barentin, L; Bonnaud, I; Moumouh, A; Serrierre, S; Tasu, JP; Tranquart, F | 1 |
| Clark, WM; Hansmann, DR; Obtera, M; Roy, RA; Singhal, R; Soltani, A | 1 |
| Al-Khaled, M; Roessler, F; Seidel, G | 1 |
| Alonso, A; Fatar, M; Griebe, M; Hennerici, M; Kern, R; Kreisel, S; Meairs, S; Stroick, M | 1 |
1 trial(s) available for sulfur hexafluoride and Brain Ischemia
| Article | Year |
|---|---|
NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study): Randomized Controlled Contrast-Enhanced Sonothrombolysis in an Unselected Acute Ischemic Stroke Population.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Female; Humans; Male; Middle Aged; Norway; Phospholipids; Population Surveillance; Prospective Studies; Single-Blind Method; Stroke; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Ultrasonography, Doppler, Transcranial | 2017 |
5 other study(ies) available for sulfur hexafluoride and Brain Ischemia
| Article | Year |
|---|---|
Safety and Tolerability of SonoVue® in Patients with Large Artery Anterior Circulation Acute Stroke.
Topics: Aged; Aged, 80 and over; Brain; Brain Ischemia; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Phospholipids; Stroke; Sulfur Hexafluoride; Thrombectomy; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2017 |
Fibrinolytic effects of transparietal ultrasound associated with intravenous infusion of an ultrasound contrast agent: study of a rat model of acute cerebral stroke.
Topics: Acute Disease; Animals; Brain; Brain Ischemia; Combined Modality Therapy; Contrast Media; Disease Models, Animal; Female; Fibrinolytic Agents; Injections, Intravenous; Magnetic Resonance Spectroscopy; Microbubbles; Photophosphorylation; Rats; Rats, Sprague-Dawley; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Ultrasonic Therapy; Ultrasonography | 2010 |
Potentiating intra-arterial sonothrombolysis for acute ischemic stroke by the addition of the ultrasound contrast agents (Optison™ & SonoVue(®)).
Topics: Albumins; Brain Ischemia; Contrast Media; Fibrinolytic Agents; Fluorocarbons; Humans; Microbubbles; Models, Cardiovascular; Phospholipids; Stroke; Sulfur Hexafluoride; Thrombolytic Therapy; Tissue Plasminogen Activator; Ultrasonography, Doppler, Transcranial | 2011 |
Microvascular imaging in acute ischemic stroke.
Topics: Aged; Brain Ischemia; Contrast Media; Echoencephalography; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Microvessels; Perfusion Imaging; Phospholipids; Reproducibility of Results; Sensitivity and Specificity; Stroke; Sulfur Hexafluoride | 2013 |
Effect of combined ultrasound and microbubbles treatment in an experimental model of cerebral ischemia.
Topics: Animals; Biomarkers; Brain Ischemia; Glutamic Acid; Glycerol; Infarction, Middle Cerebral Artery; Lactic Acid; Male; Microbubbles; Microdialysis; Middle Cerebral Artery; Models, Animal; Pyruvic Acid; Rats; Rats, Wistar; Sulfur Hexafluoride; Thrombolytic Therapy; Ultrasonography | 2008 |